C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2002
11/12/2002	US6479263 Method for detection of micrometastatic prostate cancer
11/12/2002	US6479247 Antibody for use in the treatment of cancer and arthritis
11/12/2002	US6479245 Monoclonal antibody which is specific for activated coagulation factor VII, and its use
11/12/2002	US6479243 Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
11/12/2002	CA2220684C Process for controlling sialylation of proteins produced by mammalian cell culture
11/12/2002	CA2170515C Nucleotide sequences for novel protein tyrosine phosphatases
11/12/2002	CA2169635C Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
11/12/2002	CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them
11/12/2002	CA2062820C Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
11/12/2002	CA2045875C Monoclonal antibodies to mycosphaerella species
11/07/2002	WO2002088706A2 Process for differential diagnosis of alzheimer's dementia and device therefor
11/07/2002	WO2002088384A1 Screening method
11/07/2002	WO2002088380A2 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
11/07/2002	WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme
11/07/2002	WO2002088358A2 Human fibroblast growth factor-related compositions
11/07/2002	WO2002088322A2 Cell adhesion and extracellular matrix proteins
11/07/2002	WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088307A2 Humanized antibodies
11/07/2002	WO2002088306A2 Humanized antibodies
11/07/2002	WO2002088186A1 Anti-cd40 monoclonal antibody
11/07/2002	WO2002088185A2 Pan-specific monoclonal antibody
11/07/2002	WO2002088184A1 A molecular marker
11/07/2002	WO2002088180A2 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
11/07/2002	WO2002088177A1 Erav diagnostics and vaccines
11/07/2002	WO2002088176A2 Genes and proteins for the biosynthesis of polyketides
11/07/2002	WO2002088170A2 Cripto blocking antibodies and uses thereof
11/07/2002	WO2002088164A1 Human ox2 receptors
11/07/2002	WO2002088081A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
11/07/2002	WO2002087615A1 Human polyclonal antibody compositions
11/07/2002	WO2002087611A2 Agent of human origin for vaccination against gd2 positive tumours
11/07/2002	WO2002087502A2 Antibodies abolish prion propagation and promote clearance of infectivity
11/07/2002	WO2002074980A3 Muteins of hypoxia inducible factor alpha and methods of use thereof
11/07/2002	WO2002072635A3 Specific binding members
11/07/2002	WO2002067857A3 Modified annexin proteins and methods for preventing thrombosis
11/07/2002	WO2002040649A8 Slo2 and slo4, novel potassium channel proteins from human brain
11/07/2002	WO2002038594A9 Novel therapeutic compositions for treating infection by lawsonia spp
11/07/2002	WO2002030967A3 Novel compounds
11/07/2002	WO2002030960A3 Polypeptide from haemophilus influenza
11/07/2002	WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002	WO2002022079A3 Methods of preparing immune globulin and uses thereof
11/07/2002	WO2002016561A3 Mfq-111, a novel human gtpase like protein
11/07/2002	WO2002016414A3 Composition for the elimination of autoreactive b-cells
11/07/2002	WO2001071352A3 Compositions associated with complex formation
11/07/2002	WO2001058480A9 Tubulin based vaccine against trypanosomiasis
11/07/2002	WO2001029240A9 Regeneration
11/07/2002	US20020166131 Nucleotide sequences coding polypeptide for use in the treatment of disease parkinson's, irritable bowel syndrome and cardiovascular disorders
11/07/2002	US20020165387 High affinity humanized anti-CEA monoclonal antibodies
11/07/2002	US20020165386 C-junction-n-terminal kinase (JNK); microbiocides; treating neurodegenerative diseases
11/07/2002	US20020165383 Tenebrio antifreeze proteins
11/07/2002	US20020165381 Nucleic acid that codes for an androgen receptor, consists of a prefered nucleotide sequences or nucleotide sequence that corresponds to the sequence from first, or that hydbridizes with above first and second sequences
11/07/2002	US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002	US20020165379 An isolated nucleic acid encoding a monomer of a calcium-activated potassium channel, and the monomer having molecular weight 40-80 kDa, unit conductance 2-6-pS, binding to antibodies generated against specific peptide sequence
11/07/2002	US20020165377 ADAM polynucleotides, polypeptides, and antibodies
11/07/2002	US20020165374 Secreted protein HFEAF41
11/07/2002	US20020165363 Cachexia remedy
11/07/2002	US20020165362 Specific antibody directed to active hepatocyte growth factor activator and method for using the same
11/07/2002	US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002	US20020165360 Chimeric effector cell receptors against carcinoembryonic antigen
11/07/2002	US20020165355 Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
11/07/2002	US20020165354 Nucleotide sequences coding polypeptides for use in the treatment of septic shock, cachexia, graft-versus host, autoimmune and rheumatic diseases
11/07/2002	US20020165349 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system disorder and alzheimer's disease
11/07/2002	US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis
11/07/2002	US20020165346 Isolated mammalian membrane protein genes; related reagents
11/07/2002	US20020165221 Cellular antigrowth agents
11/07/2002	US20020165193 Compositions and methods of treating tumors
11/07/2002	US20020165163 Inhibits the binding of tumor necrosis factor(TNF) to its receptors, and the cytotoxic effect of TNF; non-proteolytic protein isolated from human urine, of given amino acid sequence
11/07/2002	US20020165156 Tumor necrosis factor family and its blocking agent
11/07/2002	US20020165154 Lipoprotein-regulating medicaments
11/07/2002	US20020165150 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors
11/07/2002	US20020165143 Identification and isolation of novel DNA
11/07/2002	US20020165138 Compositions and methods for the treatment of sepsis
11/07/2002	US20020165135 Compositions and methods related to canine IgG and canine IL-13 receptors
11/07/2002	US20020165131 Histidine-rich glycoprotein
11/07/2002	US20020165127 Antidiabetic agents
11/07/2002	US20020164788 Humanized antibodies to CD38
11/07/2002	US20020164787 Immortal cell line derived from grouper Epinephelus coioides and its applications therein
11/07/2002	US20020164785 Nucleotide sequences coding membrane protein for use in the detecting ligand receptors
11/07/2002	US20020164767 DNA encoding the human serine protease C-E
11/07/2002	US20020164757 Plant proteins
11/07/2002	US20020164734 Human pelota homolog
11/07/2002	US20020164716 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
11/07/2002	US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer
11/07/2002	US20020164714 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders
11/07/2002	US20020164711 Megakaryocyte differentiation factor
11/07/2002	US20020164708 Membrane proteins for use in the treatment of cancer and the prevention of metastasis
11/07/2002	US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002	US20020164704 Novel human monocyte chemotactic proprotein
11/07/2002	US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
11/07/2002	US20020164697 Nucleotide sequences coding polypeptides for use in treatment of autoimmune disease
11/07/2002	US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies
11/07/2002	US20020164683 Human sel-10 polypeptides and polynucleotides that encode them
11/07/2002	US20020164682 Mammalian cerberus-like protein and compositions
11/07/2002	US20020164679 Polypeptides for use in the treatment of atherosclerosis and cardiovascular disorders
11/07/2002	US20020164673 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same
11/07/2002	US20020164668 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
11/07/2002	US20020164665 Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof
11/07/2002	US20020164661 Diagnostic method for a transmissible spongiform encephalopathy or a prion disease
11/07/2002	US20020164655 Protein complex for use inthe diagnosis and treatment of nervous system disorders
11/07/2002	US20020164654 Diagnosing cell proliferative disorders; obtain tissue sample, incubae with binding agent, monitor binding, evaluate for cell proliferative disorders

1 ... 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 ... 1494